Covert D - Search Results

1

Projected 24-hour post-dose ocular itching scores post-treatment with olopatadine 0.7% versus 0.2.

Fidler ML, Ogundele A, Covert D, Sarangapani R. Fidler ML, et al. Among authors: covert d. J Pharmacokinet Pharmacodyn. 2018 Aug;45(4):593-605. doi: 10.1007/s10928-018-9588-7. Epub 2018 Apr 21. J Pharmacokinet Pharmacodyn. 2018. PMID: 29680872 Free PMC article. Clinical Trial.

2

Projected impact of travoprost versus both timolol and latanoprost on visual field deficit progression and costs among black glaucoma subjects.

Halpern MT, Covert DW, Robin AL. Halpern MT, et al. Trans Am Ophthalmol Soc. 2002;100:109-17; discussion 117-8. Trans Am Ophthalmol Soc. 2002. PMID: 12545683 Free PMC article. Clinical Trial.

3

Treatment costs of cystoid macular edema among patients following cataract surgery.

Schmier JK, Covert DW, Hulme-Lowe CK, Mullins A, Mahlis EM. Schmier JK, et al. Clin Ophthalmol. 2016 Mar 16;10:477-83. doi: 10.2147/OPTH.S98892. eCollection 2016. Clin Ophthalmol. 2016. PMID: 27041989 Free PMC article.

4

An updated estimate of costs of endophthalmitis following cataract surgery among Medicare patients: 2010-2014.

Schmier JK, Hulme-Lowe CK, Covert DW, Lau EC. Schmier JK, et al. Among authors: covert dw. Clin Ophthalmol. 2016 Oct 26;10:2121-2127. doi: 10.2147/OPTH.S117958. eCollection 2016. Clin Ophthalmol. 2016. PMID: 27822008 Free PMC article.

5

Adjunctive glaucoma therapy use associated with travoprost, bimatoprost, and latanoprost.

Covert D, Robin AL. Covert D, et al. Curr Med Res Opin. 2006 May;22(5):971-6. doi: 10.1185/030079906x104777. Curr Med Res Opin. 2006. PMID: 16709319 Clinical Trial.

6

Travoprost versus latanoprost combinations in glaucoma: economic evaluation based on visual field deficit progression.

Schmier JK, Halpern MT, Covert DW, Robin AL. Schmier JK, et al. Curr Med Res Opin. 2006 Sep;22(9):1737-43. doi: 10.1185/030079906X121011. Curr Med Res Opin. 2006. PMID: 16968577 Clinical Trial.

7

Does adjunctive glaucoma therapy affect adherence to the initial primary therapy?

Robin AL, Covert D. Robin AL, et al. Among authors: covert d. Ophthalmology. 2005 May;112(5):863-8. doi: 10.1016/j.ophtha.2004.12.026. Ophthalmology. 2005. PMID: 15878067

8

Videotaped evaluation of eyedrop instillation in glaucoma patients with visual impairment or moderate to severe visual field loss.

Hennessy AL, Katz J, Covert D, Protzko C, Robin AL. Hennessy AL, et al. Among authors: covert d. Ophthalmology. 2010 Dec;117(12):2345-52. doi: 10.1016/j.ophtha.2010.03.040. Epub 2010 Jul 1. Ophthalmology. 2010. PMID: 20580092

9

Estimated first-year costs of prostaglandin analogs with/without adjunctive therapy for glaucoma management: a United States perspective.

Schmier JK, Covert DW, Robin AL. Schmier JK, et al. Curr Med Res Opin. 2007 Nov;23(11):2867-75. doi: 10.1185/030079907x233287. Curr Med Res Opin. 2007. PMID: 17922980

10

First-year treatment patterns among new initiators of topical prostaglandin analogs.

Schmier JK, Covert DW, Robin AL. Schmier JK, et al. Curr Med Res Opin. 2009 Apr;25(4):851-8. doi: 10.1185/03007990902791132. Curr Med Res Opin. 2009. PMID: 19231912

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

120 results

Search Page

Filters